Elasmogen's Unattributed Round

Elasmogen raised a round of funding on April 27, 2017.

Elasmogen is discovering and developing soloMERs for the treatment of auto-immune mediated, inflammatory diseases.…

Articles about Elasmogen's Unattributed Round: